Animal Models of Human Memory Disorders
Animal research has many practical applications to the study and treatment of human memory dysfunction. Many types of neurological disorder and brain damage can produce memory impairments in humans, and it has been possible to model some of these in animals. The first successful attempt at this was production of an animal model of brain-damaged-induced amnesia. It had been known since the 1950’s that damage to the temporal lobes, as a result of disease, traumatic injury, epilepsy, or infection, could produce a disorder known as anterograde amnesia, the inability to form new long-term memories. This is in contrast to the better-known retrograde amnesia, which is an inability to remember previously stored information. Beginning in the late 1970’s, work with monkeys, and later rats, began to identify the critical temporal lobe structures that, when damaged, produce anterograde amnesia. These structures include the hippocampus and, perhaps more important, the adjacent, overlying cortex, which is known as the rhinal cortex. As a result of this work, this brain region is now believed to be critical in the formation of new long-term memories. Memory disorders also frequently develop after an interruption of oxygen flow to the brain (known as hypoxia), which can be caused by events such as stroke, cardiac arrest, or carbon monoxide poisoning. There are a variety of animal models of stroke and resultant memory disorders. Significantly, oxygen deprivation produces brain damage that is most severe in the temporal lobe, particularly the hippocampus and the rhinal cortex. Using animal models, the mechanisms underlying hypoxic injury have been investigated, and potential therapeutic drugs designed to minimize the brain damage and lessen the memory impairments have been tested. One potentially damaging event that has been identified is a massive influx of calcium into neurons during a hypoxic episode. This has led to the development of calcium blockers and their widespread use in the clinical treatment of complications arising from stroke. Alzheimer’s disease is probably the best-known human memory disorder. It is characterized by gradual memory loss over a period of five to fifteen years. It typically begins as a mild forgetfulness and progresses to anterograde amnesia, retrograde amnesia, and eventually complete cognitive dysfunction and physical incapacitation. One pathological event that has been implicated in the development of Alzheimer’s disease is the overproduction of a protein known as the amyloid-beta protein. The normal biological function of this protein is not known, but at high levels it appears to be toxic to neurons. Amyloid-beta deposits are most pronounced and develop first in the temporal and frontal lobes, a fact that corresponds well with the memory functions ascribed to these areas and the types of deficits seen in people with Alzheimer’s disease. The development of an animal model has marked a major milestone in understanding the disorder and developing a potential treatment. Mice have been genetically engineered to overproduce the amyloid- beta protein. As a result, they develop patterns of brain damage and memory deficits similar to those in humans with Alzheimer’s disease. The development of the Alzheimer’s mouse has allowed for a comprehensive investigation of the genetics of the disorder as well as providing a model on which to test potential therapeutic treatments. Limited success for potential treatments has been obtained with an experimental vaccine in animals. This vaccine has been shown to reduce both brain damage and memory deficits. Application to the treatment of human Alzheimer’s disease is many years away.
Sources for Further Study Anagnostopoulos, Anna V., Larry E. Mobraaten, John J. Sharp, and Muriel T. Davisson. “Transgenic and Knockout Databases: Behavioral Profiles of Mouse Mutants.” Physiology and Behavior 73 (2001): 675-689. A summary of an ongoing project to construct a database of genetically engineered mice designed to facilitate the dissemination of findings among researchers. The article contains an exhaustive reference section on mutant mice and their behavioral and physiological profiles. Cohen, Neil J., and Howard Eichenbaum. Memory, Amnesia, and the Hippocampal System. Cambridge, Mass.: MIT Press, 1993. A discussion of memory impairments resulting from damage the hippocampus and adjacent brain regions. Duva, Christopher A., Thomas J. Kornecook, and John P. J. Pinel. “Animal Models of Medial Temporal Lobe Amnesia: The Myth of the Hippocampus.” In Animal Models of Human Emotion and Cognition, edited by Mark Haug and Richard E Whalen.Washington, D.C.: American Psychological Association, 1999. A critical evaluation of the role of the hippocampus in memory for objects. The article includes a historical description of human amnesia and attempts to model it in monkeys and rats. Kiefer, Steven W. “Neural Mediation of Conditioned Food Aversions.” Annals of the New York Academy of Sciences 443 (1985): 100-109. A comprehensive review of the brain areas and neural systems involved in food aversion learning. Martinez, Joe L., and Raymond P. Kesner. Neurobiology of Learning and Memory. New York: Academic Press, 1998. An overview of information on the neurobiology of learning and memory from developmental, pharmacological, and psychobiological perspectives. A good introductory source. Morgan, Dave, et al. “A Peptide Vaccination Prevents Memory Loss in an Animal Model of Alzheimer’s Disease.” Nature 408 (2000): 982-985. This original research report describes a successful attempt to vaccinate Alzheimer’s mice against the disorder and prevent memory loss. Squire, Larry R., and Eric Kandel. Memory: From Mind to Molecules. New York: Scientific American Library, 1999. An approachable volume summarizing the major developments in understanding the anatomy and physiology of vertebrate and invertebrate learning. This text contains an extensive discussion of Kandel’s work with the molecular biology of memory in Aplysia and Squires’s work on the neuroanatomy of memory with monkeys. An excellent source for people with a limited background in biology and chemistry. Tang, Ya-Ping, et al. “Genetic Enhancement of Learning and Memory in Mice.” Nature 401 (1999): 63-69. An original research report that describes how memory was improved in a strain of mice by genetically engineering them to contain an overabundance of glutamate receptors in the hippocampus. Thompson, Richard F. “The Neurobiology of Learning and Memory.” Science 233, no. 13 (1986): 941-947. The author summarizes his work on the brain mechanisms involved in classical conditioning of the eyeblink reflex in rabbits. Tulving, Endel, and Fergus I. M. Craik. The Oxford Handbook of Memory. New York: Oxford University Press, 2000. A comprehensive volume dealing with a wide variety of topics related to both animal and human memory. An excellent general reference source. Christopher A. Duva See also: Animal Experimentation; Brain Structure; Habituation and Sensitization; Memory.
198 times read
|